Cerebrospinal Fluid Cytokines and Neurodegeneration-Associated Proteins in Parkinson's Disease.
Parkinson's disease
alpha-synuclein
cerebrospinal fluid
cytokine
tau
Journal
Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
17
12
2019
revised:
12
02
2020
accepted:
13
02
2020
pubmed:
16
5
2020
medline:
24
4
2021
entrez:
16
5
2020
Statut:
ppublish
Résumé
Immune markers are altered in Parkinson's disease (PD), but relationships between cerebrospinal fluid (CSF) and plasma cytokines and associations with neurodegeneration-associated proteins remain unclear. CSF and plasma samples and demographic/clinical measures were obtained from 35 PD patients. CSF samples were analyzed for cytokines (together with plasma) and for α-synuclein, amyloid β(1-42) peptide, total tau, and phospho(Thr231)-tau. There were no CSF-plasma cytokine correlations. Interleukin (IL)-8 was higher and interferon-γ, IL-10, and tumor necrosis factor-α were lower in CSF versus plasma. In CSF, total tau correlated positively with IL-8 and IL-1β, whereas α-synuclein correlated positively with amyloid β(1-42) and negatively with semantic fluency (a known marker of PD dementia risk). CSF and peripheral cytokine profiles in PD are not closely related. Associations between CSF IL-8 and IL-1β and tau suggest that CSF inflammatory changes may relate to tau pathology within PD. CSF α-synuclein/amyloid β may reflect the risk of developing PD dementia. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Identifiants
pubmed: 32413185
doi: 10.1002/mds.28015
pmc: PMC8629119
doi:
Substances chimiques
Amyloid beta-Peptides
0
Biomarkers
0
Cytokines
0
Peptide Fragments
0
alpha-Synuclein
0
tau Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1062-1066Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_12009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R007446/1
Pays : United Kingdom
Informations de copyright
© 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Références
Brain. 2007 Jul;130(Pt 7):1787-98
pubmed: 17535834
Neurol Sci. 2017 Nov;38(11):1953-1961
pubmed: 28808876
Neurosci Lett. 1996 Jun 14;211(1):13-6
pubmed: 8809836
Front Immunol. 2018 Sep 19;9:2122
pubmed: 30283455
Mov Disord. 2016 Mar;31(3):366-76
pubmed: 26853432
Neurobiol Aging. 2015 Jan;36(1):476-84
pubmed: 25212463
J Neuroinflammation. 2017 Aug 18;14(1):164
pubmed: 28821274
Nat Rev Immunol. 2017 Jan;17(1):49-59
pubmed: 27916979
Biomed Res Int. 2014;2014:275178
pubmed: 24822191
Lancet Neurol. 2017 Jan;16(1):55-65
pubmed: 27979356
Mov Disord. 2017 Oct;32(10):1389-1400
pubmed: 28880418
J Neurol. 2015 Feb;262(2):294-306
pubmed: 25380583
Brain. 2009 Nov;132(Pt 11):2958-69
pubmed: 19812213
Cell Immunol. 2018 May;327:77-82
pubmed: 29478949
Front Neurosci. 2017 Mar 23;11:151
pubmed: 28386215
Mov Disord. 2016 Jul;31(7):995-1003
pubmed: 26999434
JAMA Neurol. 2016 Nov 1;73(11):1316-1324
pubmed: 27668667
Exp Gerontol. 2017 Aug;94:103-107
pubmed: 27979768